Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Debruyne

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Revue De Tuberculose Et De Pneumologie|July 1, 1970
[Human mycobacteriosis. Current methods of bacteriological diagnosis. Clinical, therapeutic and epidemiologic aspects]C Gernez-Rieux, A Tacquet, B Devulder, et al.
Drugs Under Experimental and Clinical Research|January 1, 1994
A prospective study in healthy volunteers of the topical absorption of a 5% rifaximin creamJ A Berlö, H J Debruyne, J P Gortz
Urology|March 12, 2004
Clinical and socioeconomic relevance of overactive bladderFrans M J Debruyne, John P F A Heesakkers
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|April 3, 2010
Opioids affect focal contact-mediated cell-substrate adhesionDelphine J Debruyne, Marc M Mareel, Marc E Bracke
Physiology & Behavior|January 7, 1999
Circadian rhythms of locomotor activity in zebrafishM W Hurd, J Debruyne, M Straume, et al.
International Journal of Impotence Research|September 11, 2023
The post-finasteride syndrome: possible etiological mechanisms and symptomsHerman H J Leliefeld, Frans M J Debruyne, Yakov Reisman
Current Opinion in Urology|August 13, 2002
Important factors in the diagnosis and primary staging of testicular tumoursJ Roan Spermon, Frans M J Debruyne, J Alfred Witjes
Clinical Neurology and Neurosurgery|November 1, 1996
In vitro TNF-alpha, IL-2 and IFN-gamma production as markers of relapses in multiple sclerosisJ Philippé, J Debruyne, G Leroux-Roels, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 1998
Relapse markers in multiple sclerosis: are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations?J Debruyne, J Philippé, J Dereuck, et al.
European Urology|September 12, 2021
Reply to Bexultan Kazybay and Yingqiu Xie's Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024Herjan J T Coelingh Bennink, Jean-Michel Foidart, Frans M J Debruyne
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Revue De Tuberculose Et De Pneumologie|July 1, 1970
[Human mycobacteriosis. Current methods of bacteriological diagnosis. Clinical, therapeutic and epidemiologic aspects]C Gernez-Rieux, A Tacquet, B Devulder, et al.
Drugs Under Experimental and Clinical Research|January 1, 1994
A prospective study in healthy volunteers of the topical absorption of a 5% rifaximin creamJ A Berlö, H J Debruyne, J P Gortz
Urology|March 12, 2004
Clinical and socioeconomic relevance of overactive bladderFrans M J Debruyne, John P F A Heesakkers
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|April 3, 2010
Opioids affect focal contact-mediated cell-substrate adhesionDelphine J Debruyne, Marc M Mareel, Marc E Bracke
Physiology & Behavior|January 7, 1999
Circadian rhythms of locomotor activity in zebrafishM W Hurd, J Debruyne, M Straume, et al.
International Journal of Impotence Research|September 11, 2023
The post-finasteride syndrome: possible etiological mechanisms and symptomsHerman H J Leliefeld, Frans M J Debruyne, Yakov Reisman
Current Opinion in Urology|August 13, 2002
Important factors in the diagnosis and primary staging of testicular tumoursJ Roan Spermon, Frans M J Debruyne, J Alfred Witjes
Clinical Neurology and Neurosurgery|November 1, 1996
In vitro TNF-alpha, IL-2 and IFN-gamma production as markers of relapses in multiple sclerosisJ Philippé, J Debruyne, G Leroux-Roels, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 1998
Relapse markers in multiple sclerosis: are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations?J Debruyne, J Philippé, J Dereuck, et al.
European Urology|September 12, 2021
Reply to Bexultan Kazybay and Yingqiu Xie's Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024Herjan J T Coelingh Bennink, Jean-Michel Foidart, Frans M J Debruyne
Pageof 8